FTC gives the OK for UnitedHealth's acquisition of DaVita Medical Group

dialysis
UnitedHealth's Optum unit has completed its $4.3 billion acquisition of DaVita Medical Group after getting the final OK from the Federal Trade Commission. (Getty/Jupiterimages)

UnitedHealth's Optum unit has completed its $4.3 billion acquisition of DaVita Medical Group after getting the final OK from the Federal Trade Commission (FTC).

As part of the deal, HealthCare Partners Nevada—which is DaVita Medical Group’s primary care practice in southern Nevada—will become part of Intermountain Healthcare. It was part of a settlement with the FTC to resolve allegations the acquisition could harm competition in healthcare markets in Clark and Nye counties, Nevada.

 RELATED: Optum’s $4.9B deal to buy DaVita Medical Group further expands UnitedHealth’s care delivery portfolio

“We are excited to take this important step in building a next-generation comprehensive, coordinated health care organization. Together we will improve patient health and experiences while lowering costs across the continuum of care—including primary, specialty, urgent and surgical care,” said Andrew Witty, CEO of Optum, in a statement.

It was first announced in 2017 that Optum would acquire DaVita's medical group, one of the nation’s biggest, for $4.9 billion in cash. The company said DaVita Medical Group will join Optum’s physician-led primary, specialty, in-home, urgent and surgery care delivery services business.

Suggested Articles

Consumer groups are urging regulators to scrutinize Google's $2.1 billion bid for Fitbit, citing privacy and competition concerns.

A collection of unions, business and health groups are imploring Congress to take up a forgotten health policy issue: surprise billing.

Health benefits platform Accolade made its debut on the public market Thursday, raising $220 million at a valuation of $1.2 billion.